![]() Alcresta Alcresta develops enzyme-based nutritional products for infants and adults with acute and chronic diseases. | ![]() NanoDx NanoDx (formerly known as BioDirection) is a medical device company developing point-of-care technologies to diagnose and manage concussion and other traumatic brain injuries (TBI). | ||
Founding Date | Founding Date 2020 | Founding Date 2011 | Founding Date 2010 |
Type | Type Private | Type Private | Type Private |
Tags | |||
Locations | Locations Westminster, US HQ | Locations Newton, US HQ | Locations Southborough, US HQ Albuquerque, US |
Employees | Employees 20 | Employees 82 | Employees 39 |
Funding | |||
Latest funding round | Latest funding round N/A | Latest funding round $ 60m (over 8 years ago) | Latest funding round $ 18m (almost 6 years ago) |
Total funding raised | Total funding raised N/A | Total funding raised $ 139.4m | Total funding raised $ 35.6m |

Alcresta develops enzyme-based nutritional products for infants and adults with acute and chronic diseases.
View company
NanoDx (formerly known as BioDirection) is a medical device company developing point-of-care technologies to diagnose and manage concussion and other traumatic brain injuries (TBI).
View company